BBUC Brookfld Biz CEO outlines crosssector investment plans to boost longterm organic growth momentum PCSA Processa Pharmaceuticals posts worsethanexpected Q4 2025 EPS results that miss estimates by 68 percent as shares edge 033 percent lower OLB The OLB rises 23 percent after Q4 2025 earnings outpace consensus analyst EPS estimates US Equity and Global Oil Market Performance Amid Middle East Deescalation Signals Is it too late to buy Scully Royalty SRL stock today Scully Royalty posts 8193 EPS blowout trouncing estimates